Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Randomized,Double-blind, Placebo-controlled, Study of the Efficacy of Green Tea Extract on Biomarkers of Breast Cancer Risk in High Risk Women With Differing Catechol-O-methyl Transferase (COMT) Genotypes

NCT00917735 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT00917735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00917735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Randomized,Double-blind, Placebo-controlled, Study of the Efficacy of Green Tea Extract on Biomarkers of Breast Cancer Risk in High Risk Women With Differing Catechol-O-methyl Transferase (COMT) Genotypes
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
June 30, 2014
Enrollment
1,075 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer